Status:
COMPLETED
Clinical Evaluation of Localized Scalp Thread Embedding for Male Androgenetic Alopecia
Lead Sponsor:
Beijing University of Chinese Medicine, Shenzhen Hospital
Conditions:
Androgenetic Alopecia
Eligibility:
MALE
18-50 years
Phase:
NA
Brief Summary
This clinical study aims to evaluate a breakthrough treatment for hair loss (androgenetic alopecia, AGA) using dissolvable threads placed under the scalp skin. The investigators hypothesize that these...
Eligibility Criteria
Inclusion
- Male sex
- Age 18-50 years
- No clinically significant comorbidities
- Androgenetic alopecia (Hamilton-Norwood III-V)
- No systemic anti-hair loss therapy use within 3 months
- No topical hair regrowth agent use within 3 months
Exclusion
- Active scalp infection
- Scalp psoriasis
- Scalp eczema
- Open scalp wounds
- Allergy to thread materials
- Uncontrolled diabetes mellitus
- Immunodeficiency disorders
- Non-compliance with follow-up visits
- Refusal to provide informed consent
- Investigator-deemed contraindications
Key Trial Info
Start Date :
May 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2021
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT06879119
Start Date
May 27 2021
End Date
November 25 2021
Last Update
March 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dongfang Hospital Beijing University of Chinese Medicine
Beijing, Beijing Municipality, China